[1] Mintz GS, Pichard AD, Kent K, et al. Endovascular stents reduce restenosis by eliminating geometric arterial remodeling:a serial intravascrlandtrasound intravascular-uhrasound study[J]. J Am Coll Cardiol, 1995, 35A:701-705.
[2] Teristein PS. Gamma versus beta radiation for the treament of restenosis[J]. Herz, 1998, 23:335-336.
[3] Amols HI, Trichter F, Weinberger J. Intracoronary radiation for prevention of restenosis:dose perturbation caused by stents[J].Circulation, 1998, 98:2024-2029.
[4] Kotzerke J, Rentschler M, Glatting G, et al. Dosimetry fundamentals of endovsacular therapy using Re-188 for the prevention of restenosis after angioplasty[J]. Nuklerarmedizin, 1998, 37(2):68-72.
[5] Nath RC. Intravascular brachytherapy physics:report of AAPM Radiation Therapy Committee Task Group No.60[J]. Med Phys, 1999, 26:119-152.
[6] Cousey BM, Colle R, Zimmerman BE. National radioactivity standards for beta-emitting radionnuclides used in intravascular brachytherapy[J]. Int J Radiat Oncol Bid Phys, 1998, 41:207-216.
[7] Wohlfrom M, Kotzerke J, Kamenz J, et al. Endovascular irradiation with the liquid beta-emitter Rhenium-188 to reduce restenosis after experimental wall injury[J].Cardivasc Res, 2001, 49(1):169-176.
[8] Lee J, Lee DS, Kim KM, et al. Dosimetry of rheniun-188 diethylene triamine penta-acetic acid for endvascular intraballoon brachytherapy after coronary angioplasty[J]. Eur J Nucl Med, 2000, 27(1):76-82.
[9] Janicki C, Duggan DM, Coffey CW. Radiation dose from a phosphorous-32 impregnated wire mesh vascular stent[J]. Med Phys, 1997, 24:437-445.
[10] Hehrlein C, Gollan C, Donges K, et al. Low-dose radioactive endovascular stentts prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits[J]. Circulation, 1995, 92(6):1570-1575.
[11] Weiberger J. Use of liquid-filled balloons for coronary irradiation[A] In:Waksman R,ed. Vascular brachytherapy[M], 2nd edn. Armon, New York:futura, 1999. 521-536.
[12] Makkar R, Whiting J, Li A, et al. Abeta-emitting liquid isotope filled balloon markedly inhibits restenosis in stented porcine coronary arteries[J]. J Am Coll Cardiol, 1998, 31(Suppl A):350A.
[13] Condado JA, Waksman R, Calderas C, et al. Two-year follow-up after intracoronary gamma radiation therapy[J]. Cardiovasc Radiat Med, 1999, 1(1):30-35.
[14] Coen VL, Knook AH, Wardeh AJ, et al. Endovascular brachytherapy in coronary arteries:the rotterdam experience[J]. Cardiovasc Radiat Med, 2000, 2(1):42-50.
[15] Fox RA, Barker P, Guy D, et al. The use of 188Re to treat instent re-stenosis of coronary arteries[J]. Australas Phys Eng Sci Med, 2001, 24(3):160-165.
[16] Amols HI. Methods to improve dose uniformity for radioactive stents in endovascular brachytherapy[J]. Cardiovasc Radiat Med, 1999, 1(3):270-277.
[17] Giap H, Massullo V, Teirstein P, et al. Theoretical assessment of late cardiac complication from endovascular brachytherapy for restenosis prevention[J]. Cardiovasc Radiat Med, 1999, 1(3):233-238.
[18] Teirstein PS, Massullo V, Jani S, et al. Two-year follow-up after catheter-based radiotherapy to inhibit coronary restenosis[J]. Circulation, 1999, 99(2):243-247.
[19] Xu Z, Yang G, Reinstein LE, et al. Caculation of dose distribution near an innovative concentric balloon catheter for endovascular brachytherapy[J]. Cardiovasc Radiat Med, 2000, 2(1):26-31.